The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for International Finance Corporation
ARTEMISMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.5 pts more than Nifty Microcap 250 and 4.1 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
International Finance Corporation (IFC), a global development finance institution, acquired 1,89,62,247 equity shares (11.99% of share capital) of Artemis Medicare Services on November 15, 2025, through the conversion of 33,000 compulsorily convertible debentures (CCDs) at a pre-agreed price of INR 174.03 per share. The CCDs had been allotted to IFC in May 2024 under a Subscription Agreement dated April 5, 2024, and matured/were converted as scheduled. Separately, 4,11,59,625 shares (26.02% of share capital) held by promoter entity Constructive Finance Private Limited (CFPL) remain encumbered in IFC's favour under a non-disposal undertaking tied to a Share Retention Agreement, requiring promoters to maintain at least 26% voting interest. The total share capital of the company rose from INR 13.92 crore to INR 15.82 crore because of the conversion.
This signals strong long-term institutional commitment from a high-profile global investor and brings a credible foreign stakeholder onto the cap table, generally positive for sentiment. Promoter stability is reinforced via the retention lock-in, though the encumbrance on a large block of promoter shares is a structural overhang retail investors should be aware of.